| RS1323140900 |
SYNE2
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1323151304 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1323153568 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4A |
| RS1323156960 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS1323162486 |
SCN9A
|
Health Risk |
Pathogenic |
Channelopathy-associated congenital insensitivity to pain, autosomal recessive |
| RS1323174734 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS1323188207 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS1323197030 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS1323211736 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1323224189 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1323236841 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1323279729 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1323302393 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1323329701 |
OTOF
|
Health Risk |
Likely pathogenic |
— |
| RS1323334420 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Maturity-onset diabetes of the young |
| RS1323337681 |
GALK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of galactokinase, Inborn genetic diseases |
| RS1323339153 |
NEUROD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 72 |
| RS1323340608 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1323349209 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS1323364980 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1323401541 |
IDH3B
|
Health Risk |
Pathogenic |
— |
| RS1323402380 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1323416354 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1323426610 |
DNM1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS1323430299 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1323449085 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Polyps |
| RS1323477178 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1323477202 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS1323481821 |
EMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1323488764 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1323512637 |
ALG8
|
Health Risk |
Likely pathogenic |
ALG8 congenital disorder of glycosylation, Polycystic liver disease 3 with or without kidney cysts |
| RS1323513432 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1323514351 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1323529877 |
CEP164
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS1323542030 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1323557941 |
CIB1
|
Health Risk |
risk factor |
Epidermodysplasia verruciformis, susceptibility to |
| RS1323578421 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS1323588796 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1323608032 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1323617205 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1323623166 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1323639275 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS1323647622 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Saldino-Mainzer syndrome |
| RS1323663956 |
PROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS1323688594 |
FLAD1
|
Health Risk |
Likely pathogenic |
— |
| RS1323688837 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1323697541 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1323703791 |
ADARB1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, microcephaly |
| RS1323709805 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1323715274 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1323743578 |
PIK3AP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile spasms, Infantile spasms |
| RS1323766758 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1323771026 |
TJP2
|
Health Risk |
Pathogenic |
— |
| RS1323772321 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1323783290 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS1323802111 |
XYLT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS1323803461 |
IMPG1
|
Health Risk |
Pathogenic |
— |
| RS1323805020 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1323823133 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS1323841528 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS1323849138 |
TWIST1
|
Health Risk |
Pathogenic |
Sweeney-Cox syndrome, Sweeney-Cox syndrome |
| RS1323862623 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1323878836 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome |
| RS1323881530 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1323896467 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1323923681 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS1323938116 |
PLPBP
|
Health Risk |
Pathogenic |
— |
| RS1323940169 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1323946751 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1323958195 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS1323969534 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1323987464 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1323994245 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1323998441 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1323999679 |
NSDHL
|
Health Risk |
Conflicting classifications of pathogenicity |
CK syndrome, Child syndrome |
| RS1324005699 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1324022945 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1324026596 |
TBC1D7
|
Health Risk |
Pathogenic |
— |
| RS1324029062 |
NRROS
|
Health Risk |
Pathogenic |
Seizures, early-onset |
| RS1324029651 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1324032838 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1324044951 |
PKLR
|
Health Risk |
Likely pathogenic |
— |
| RS1324062430 |
ALG9
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG9-associated autosomal dominant polycystic kidney disease, ALG9-associated autosomal dominant polycystic kidney disease |
| RS1324075885 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1324077575 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1324080523 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS1324081394 |
SOX9
|
Health Risk |
Pathogenic/Likely pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS1324088403 |
EPCAM
|
Health Risk |
Pathogenic |
Congenital diarrhea 5 with tufting enteropathy, Congenital diarrhea 5 with tufting enteropathy |
| RS1324100572 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1324125372 |
LITAF
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1C, Charcot-Marie-Tooth disease |
| RS1324141092 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS1324147964 |
KANSL1
|
Health Risk |
Likely pathogenic |
— |
| RS1324157182 |
COL9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
COL9A3-related disorder, COL9A3-related disorder |
| RS1324200224 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome |
| RS1324209174 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease |
| RS1324211895 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1324229618 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1324238938 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS1324242791 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1324244950 |
MYO7A
|
Health Risk |
Pathogenic |
— |